Nicotinamide/nicotinic acid mononucleotide adenylyltransferase, new insights into an ancient enzyme
- PMID: 19448972
- PMCID: PMC11115848
- DOI: 10.1007/s00018-009-0047-x
Nicotinamide/nicotinic acid mononucleotide adenylyltransferase, new insights into an ancient enzyme
Abstract
Nicotinamide/nicotinic acid mononucleotide adenylyltransferase (NMNAT) has long been known as the master enzyme in NAD biosynthesis in living organisms. A burst of investigations on NMNAT, going beyond enzymology, have paralleled increasing discoveries of key roles played by NAD homeostasis in a number or patho-physiological conditions. The availability of in-depth kinetics and structural enzymology analyses carried out on NMNATs from different organisms offer a powerful tool for uncovering fascinating evolutionary relationships. On the other hand, additional functions featuring NMNAT have emerged from investigations aimed at unraveling the molecular mechanisms responsible for complex biological phenomena such as neurodegeneration. NMNAT appears to be a multifunctional protein that sits both at the core of central metabolism and at a crossroads of multiple cellular processes. The resultant wealth of biochemical data has built a robust framework upon which design of NMNAT activators, inhibitors or enzyme variants of potential medical interest can be based.
Figures






Similar articles
-
The NMN/NaMN adenylyltransferase (NMNAT) protein family.Front Biosci (Landmark Ed). 2009 Jan 1;14(2):410-31. doi: 10.2741/3252. Front Biosci (Landmark Ed). 2009. PMID: 19273075 Review.
-
Structure and function of nicotinamide mononucleotide adenylyltransferase.Curr Med Chem. 2004 Apr;11(7):873-85. doi: 10.2174/0929867043455666. Curr Med Chem. 2004. PMID: 15078171 Review.
-
YCL047C/POF1 is a novel nicotinamide mononucleotide adenylyltransferase (NMNAT) in Saccharomyces cerevisiae.J Biol Chem. 2014 May 30;289(22):15577-87. doi: 10.1074/jbc.M114.558643. Epub 2014 Apr 23. J Biol Chem. 2014. PMID: 24759102 Free PMC article.
-
Nicotinamide mononucleotide adenylyltransferase displays alternate binding modes for nicotinamide nucleotides.Acta Crystallogr D Biol Crystallogr. 2015 Oct;71(Pt 10):2032-9. doi: 10.1107/S1399004715015497. Epub 2015 Sep 26. Acta Crystallogr D Biol Crystallogr. 2015. PMID: 26457427 Free PMC article.
-
Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms.J Biol Chem. 2005 Oct 28;280(43):36334-41. doi: 10.1074/jbc.M508660200. Epub 2005 Aug 23. J Biol Chem. 2005. PMID: 16118205
Cited by
-
Nicotinamide Mononucleotide Adenylyltransferase 1 Regulates Cerebral Ischemia-Induced Blood-Brain Barrier Disruption Through NAD+/SIRT1 Signaling Pathway.Mol Neurobiol. 2022 Aug;59(8):4879-4891. doi: 10.1007/s12035-022-02903-6. Epub 2022 Jun 3. Mol Neurobiol. 2022. PMID: 35657458
-
CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy.Hum Mol Genet. 2012 Jan 15;21(2):251-67. doi: 10.1093/hmg/ddr492. Epub 2011 Oct 25. Hum Mol Genet. 2012. PMID: 22027994 Free PMC article.
-
Nicotinamide mononucleotide adenylyl transferase 1 protects against acute neurodegeneration in developing CNS by inhibiting excitotoxic-necrotic cell death.Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):19054-9. doi: 10.1073/pnas.1107325108. Epub 2011 Nov 4. Proc Natl Acad Sci U S A. 2011. PMID: 22058226 Free PMC article.
-
Nmnat exerts neuroprotective effects in dendrites and axons.Mol Cell Neurosci. 2011 Sep;48(1):1-8. doi: 10.1016/j.mcn.2011.05.002. Epub 2011 May 9. Mol Cell Neurosci. 2011. PMID: 21596138 Free PMC article.
-
Nicotinamide Mononucleotide Adenylyltransferase 1 Protects Neural Cells Against Ischemic Injury in Primary Cultured Neuronal Cells and Mouse Brain with Ischemic Stroke Through AMP-Activated Protein Kinase Activation.Neurochem Res. 2015 Jun;40(6):1102-10. doi: 10.1007/s11064-015-1569-2. Epub 2015 Apr 5. Neurochem Res. 2015. PMID: 25841561
References
-
- Gerdes SY, Scholle MD, D’Souza M, Bernal A, Baev MV, Farrell M, Kurnasov OV, Daugherty MD, Mseeh F, Polanuyer BM, Campbell JW, Anantha S, Shatalin KY, Chowdhury SA, Fonstein MY, Osterman AL. From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways. J Bacteriol. 2002;184:4555–4572. doi: 10.1128/JB.184.16.4555-4572.2002. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources